HEADER TRANSCRIPTION 26-AUG-22 8E9F TITLE WD REPEAT-CONTAINING PROTEIN 5 COMPLEXED WITH 4-(7-((1H-IMIDAZOL-1- TITLE 2 YL)METHYL)-5-(1-METHYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-4-YL)-1-OXO-3, TITLE 3 4-DIHYDROISOQUINOLIN-2(1H)-YL)-6-ETHYL-N-METHYLQUINOLINE-8- TITLE 4 CARBOXAMIDE (COMPOUND 10) COMPND MOL_ID: 1; COMPND 2 MOLECULE: WD REPEAT-CONTAINING PROTEIN 5; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: BMP2-INDUCED 3-KB GENE PROTEIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: WDR5, BIG3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS WDR5, DRUG DISCOVERY, CANCER, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR T.A.RIETZ,S.W.FESIK REVDAT 2 25-OCT-23 8E9F 1 REMARK REVDAT 1 11-JAN-23 8E9F 0 JRNL AUTH K.B.TEUSCHER,S.CHOWDHURY,K.M.MEYERS,J.TIAN,J.SAI, JRNL AUTH 2 M.VAN MEVEREN,T.M.SOUTH,J.L.SENSINTAFFAR,T.A.RIETZ, JRNL AUTH 3 S.GOSWAMI,J.WANG,B.C.GRIEB,S.L.LOREY,G.C.HOWARD,Q.LIU, JRNL AUTH 4 W.J.MOORE,G.M.STOTT,W.P.TANSEY,T.LEE,S.W.FESIK JRNL TITL STRUCTURE-BASED DISCOVERY OF POTENT WD REPEAT DOMAIN 5 JRNL TITL 2 INHIBITORS THAT DEMONSTRATE EFFICACY AND SAFETY IN JRNL TITL 3 PRECLINICAL ANIMAL MODELS. JRNL REF PROC.NATL.ACAD.SCI.USA V. 120 97120 2023 JRNL REFN ESSN 1091-6490 JRNL PMID 36574664 JRNL DOI 10.1073/PNAS.2211297120 REMARK 2 REMARK 2 RESOLUTION. 1.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20_4459 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.56 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 42518 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.160 REMARK 3 R VALUE (WORKING SET) : 0.159 REMARK 3 FREE R VALUE : 0.184 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.840 REMARK 3 FREE R VALUE TEST SET COUNT : 2057 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.5600 - 3.8200 0.99 2884 158 0.1436 0.1673 REMARK 3 2 3.8200 - 3.0300 1.00 2783 153 0.1412 0.1454 REMARK 3 3 3.0300 - 2.6500 1.00 2747 133 0.1607 0.1923 REMARK 3 4 2.6500 - 2.4000 1.00 2716 123 0.1670 0.1792 REMARK 3 5 2.4000 - 2.2300 1.00 2748 135 0.1638 0.1986 REMARK 3 6 2.2300 - 2.1000 1.00 2707 130 0.1549 0.1640 REMARK 3 7 2.1000 - 2.0000 1.00 2702 121 0.1590 0.1921 REMARK 3 8 2.0000 - 1.9100 1.00 2706 118 0.1639 0.2232 REMARK 3 9 1.9100 - 1.8400 1.00 2682 138 0.1689 0.2198 REMARK 3 10 1.8400 - 1.7700 1.00 2654 150 0.1720 0.2196 REMARK 3 11 1.7700 - 1.7200 0.99 2638 131 0.1742 0.2295 REMARK 3 12 1.7200 - 1.6700 0.99 2707 126 0.1834 0.2214 REMARK 3 13 1.6700 - 1.6200 0.99 2623 153 0.1916 0.2048 REMARK 3 14 1.6200 - 1.5800 0.99 2616 160 0.2165 0.2832 REMARK 3 15 1.5800 - 1.5500 0.95 2548 128 0.2415 0.2719 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.156 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 18.180 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.31 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.01 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 2487 REMARK 3 ANGLE : 0.888 3384 REMARK 3 CHIRALITY : 0.065 374 REMARK 3 PLANARITY : 0.007 417 REMARK 3 DIHEDRAL : 11.797 334 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8E9F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-AUG-22. REMARK 100 THE DEPOSITION ID IS D_1000268056. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-FEB-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-G REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97856 REMARK 200 MONOCHROMATOR : C(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-300 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42739 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.550 REMARK 200 RESOLUTION RANGE LOW (A) : 29.560 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 7.900 REMARK 200 R MERGE (I) : 0.07900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 38.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.55 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.58 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.90 REMARK 200 R MERGE FOR SHELL (I) : 0.63000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3EG6 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.47 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: BIS-TRIS, AMMONIUM ACETATE, PEG 3350, REMARK 280 BENZAMIDINE, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 40.68050 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.02000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 40.68050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.02000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 736 O HOH A 826 1.49 REMARK 500 O HOH A 622 O HOH A 714 1.58 REMARK 500 O HOH A 790 O HOH A 803 1.70 REMARK 500 O HOH A 578 O HOH A 614 1.72 REMARK 500 O HOH A 702 O HOH A 726 1.77 REMARK 500 O HOH A 700 O HOH A 747 1.92 REMARK 500 O HOH A 740 O HOH A 772 1.99 REMARK 500 O HOH A 597 O HOH A 741 2.02 REMARK 500 O HOH A 552 O HOH A 791 2.04 REMARK 500 O HOH A 674 O HOH A 717 2.05 REMARK 500 O HOH A 617 O HOH A 618 2.08 REMARK 500 O HOH A 831 O HOH A 833 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 757 O HOH A 757 2555 1.73 REMARK 500 O HOH A 810 O HOH A 820 3556 1.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 109 7.76 80.74 REMARK 500 GLU A 151 2.91 81.12 REMARK 500 LEU A 234 34.98 -83.41 REMARK 500 LYS A 259 -46.82 -131.47 REMARK 500 REMARK 500 REMARK: NULL DBREF 8E9F A 30 334 UNP P61964 WDR5_HUMAN 30 334 SEQRES 1 A 305 PRO VAL LYS PRO ASN TYR ALA LEU LYS PHE THR LEU ALA SEQRES 2 A 305 GLY HIS THR LYS ALA VAL SER SER VAL LYS PHE SER PRO SEQRES 3 A 305 ASN GLY GLU TRP LEU ALA SER SER SER ALA ASP LYS LEU SEQRES 4 A 305 ILE LYS ILE TRP GLY ALA TYR ASP GLY LYS PHE GLU LYS SEQRES 5 A 305 THR ILE SER GLY HIS LYS LEU GLY ILE SER ASP VAL ALA SEQRES 6 A 305 TRP SER SER ASP SER ASN LEU LEU VAL SER ALA SER ASP SEQRES 7 A 305 ASP LYS THR LEU LYS ILE TRP ASP VAL SER SER GLY LYS SEQRES 8 A 305 CYS LEU LYS THR LEU LYS GLY HIS SER ASN TYR VAL PHE SEQRES 9 A 305 CYS CYS ASN PHE ASN PRO GLN SER ASN LEU ILE VAL SER SEQRES 10 A 305 GLY SER PHE ASP GLU SER VAL ARG ILE TRP ASP VAL LYS SEQRES 11 A 305 THR GLY LYS CYS LEU LYS THR LEU PRO ALA HIS SER ASP SEQRES 12 A 305 PRO VAL SER ALA VAL HIS PHE ASN ARG ASP GLY SER LEU SEQRES 13 A 305 ILE VAL SER SER SER TYR ASP GLY LEU CYS ARG ILE TRP SEQRES 14 A 305 ASP THR ALA SER GLY GLN CYS LEU LYS THR LEU ILE ASP SEQRES 15 A 305 ASP ASP ASN PRO PRO VAL SER PHE VAL LYS PHE SER PRO SEQRES 16 A 305 ASN GLY LYS TYR ILE LEU ALA ALA THR LEU ASP ASN THR SEQRES 17 A 305 LEU LYS LEU TRP ASP TYR SER LYS GLY LYS CYS LEU LYS SEQRES 18 A 305 THR TYR THR GLY HIS LYS ASN GLU LYS TYR CYS ILE PHE SEQRES 19 A 305 ALA ASN PHE SER VAL THR GLY GLY LYS TRP ILE VAL SER SEQRES 20 A 305 GLY SER GLU ASP ASN LEU VAL TYR ILE TRP ASN LEU GLN SEQRES 21 A 305 THR LYS GLU ILE VAL GLN LYS LEU GLN GLY HIS THR ASP SEQRES 22 A 305 VAL VAL ILE SER THR ALA CYS HIS PRO THR GLU ASN ILE SEQRES 23 A 305 ILE ALA SER ALA ALA LEU GLU ASN ASP LYS THR ILE LYS SEQRES 24 A 305 LEU TRP LYS SER ASP CYS HET BEN A 401 9 HET UY9 A 402 43 HETNAM BEN BENZAMIDINE HETNAM UY9 6-ETHYL-4-[(5P)-7-[(1H-IMIDAZOL-1-YL)METHYL]-5-[1- HETNAM 2 UY9 METHYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-4-YL]-1-OXO-3,4- HETNAM 3 UY9 DIHYDROISOQUINOLIN-2(1H)-YL]-N-METHYLQUINOLINE-8- HETNAM 4 UY9 CARBOXAMIDE FORMUL 2 BEN C7 H8 N2 FORMUL 3 UY9 C31 H28 F3 N7 O2 FORMUL 4 HOH *335(H2 O) SHEET 1 AA1 4 ALA A 36 LEU A 41 0 SHEET 2 AA1 4 ILE A 327 LYS A 331 -1 O ILE A 327 N LEU A 41 SHEET 3 AA1 4 ILE A 315 ALA A 320 -1 N ILE A 316 O TRP A 330 SHEET 4 AA1 4 VAL A 304 CYS A 309 -1 N ALA A 308 O ALA A 317 SHEET 1 AA2 4 VAL A 48 PHE A 53 0 SHEET 2 AA2 4 TRP A 59 SER A 64 -1 O ALA A 61 N LYS A 52 SHEET 3 AA2 4 ILE A 69 GLY A 73 -1 O TRP A 72 N LEU A 60 SHEET 4 AA2 4 PHE A 79 ILE A 83 -1 O ILE A 83 N ILE A 69 SHEET 1 AA3 4 ILE A 90 TRP A 95 0 SHEET 2 AA3 4 LEU A 101 SER A 106 -1 O VAL A 103 N ALA A 94 SHEET 3 AA3 4 THR A 110 ASP A 115 -1 O TRP A 114 N LEU A 102 SHEET 4 AA3 4 CYS A 121 LYS A 126 -1 O LEU A 125 N LEU A 111 SHEET 1 AA4 4 VAL A 132 PHE A 137 0 SHEET 2 AA4 4 LEU A 143 SER A 148 -1 O VAL A 145 N ASN A 136 SHEET 3 AA4 4 VAL A 153 ASP A 157 -1 O TRP A 156 N ILE A 144 SHEET 4 AA4 4 CYS A 163 LEU A 167 -1 O LEU A 167 N VAL A 153 SHEET 1 AA5 4 VAL A 174 PHE A 179 0 SHEET 2 AA5 4 LEU A 185 SER A 190 -1 O VAL A 187 N HIS A 178 SHEET 3 AA5 4 CYS A 195 ASP A 199 -1 O TRP A 198 N ILE A 186 SHEET 4 AA5 4 CYS A 205 LEU A 209 -1 O LEU A 209 N CYS A 195 SHEET 1 AA6 4 VAL A 217 PHE A 222 0 SHEET 2 AA6 4 TYR A 228 THR A 233 -1 O LEU A 230 N LYS A 221 SHEET 3 AA6 4 THR A 237 ASP A 242 -1 O TRP A 241 N ILE A 229 SHEET 4 AA6 4 LYS A 247 TYR A 252 -1 O LYS A 247 N ASP A 242 SHEET 1 AA7 4 ALA A 264 SER A 267 0 SHEET 2 AA7 4 TRP A 273 SER A 276 -1 O VAL A 275 N ASN A 265 SHEET 3 AA7 4 VAL A 283 ASN A 287 -1 O TYR A 284 N SER A 276 SHEET 4 AA7 4 ILE A 293 LEU A 297 -1 O VAL A 294 N ILE A 285 CRYST1 81.361 86.040 41.032 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012291 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011623 0.000000 0.00000 SCALE3 0.000000 0.000000 0.024371 0.00000